| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/21/2007 | EP1753437A1 Bicarbonate-based peritoneal dialysis solutions |
| 02/21/2007 | EP1753436A2 Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle |
| 02/21/2007 | EP1753434A2 Enhanced bimatoprost ophthalmic solution |
| 02/21/2007 | EP1753412A1 Self-heating pharmaceutical patch |
| 02/21/2007 | EP1753411A2 Methods of manufacture and use of calcium phosphate particles containing allergens |
| 02/21/2007 | EP1753410A1 Multi-layered controlled-release methylphenidate pellet |
| 02/21/2007 | EP1753409A2 Dosage form containing the active ingredient cholylsarcosine |
| 02/21/2007 | EP1753408A1 Hormonal contraceptive containing a combination of ethinyl estradiol and chlormadinone acetate |
| 02/21/2007 | EP1753407A2 Sugar coatings and methods therefor |
| 02/21/2007 | EP1753406A1 Coated tablet formulation and method |
| 02/21/2007 | EP1753405A1 Controlled release pharmaceutical formulation |
| 02/21/2007 | EP1753404A1 Microspheres comprising protein and showing injectability at high concentrations of said agent |
| 02/21/2007 | EP1753403A1 Particulate comprising a calcium-containing compound and a sugar alcohol |
| 02/21/2007 | EP1753402A2 Pharmaceutical compositions with enhanced performance |
| 02/21/2007 | EP1753401A1 Rapidly soluble granulate of bromohexine or bromohexine hydrochloride, method for the production of said granulate and the use thereof |
| 02/21/2007 | EP1753400A2 Ziprasidone dosage form |
| 02/21/2007 | EP1753399A1 Methods to control termites |
| 02/21/2007 | EP1753398A2 Controlled release matrix pharmaceutical dosage formulation |
| 02/21/2007 | EP1753397A2 Galantamine salts, method of producing it and nasal composition thereof |
| 02/21/2007 | EP1753396A2 Composite material for use as protein carrier |
| 02/21/2007 | EP1753395A2 Enteric solid oral dosage form of a bisphosphonate containing a chelating agent |
| 02/21/2007 | EP1753382A1 An absorbent article containing fragrance |
| 02/21/2007 | EP1753381A1 An absorbent article containing fragrance |
| 02/21/2007 | EP1753380A2 Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
| 02/21/2007 | EP1753305A1 Liquid nutritional supplement and method for preparing same |
| 02/21/2007 | EP1753293A2 Anti-microbial activity of biologically stabilized silver nano particles |
| 02/21/2007 | EP1753290A2 Sealed capsule including and integrated puncturing mechanism |
| 02/21/2007 | EP1753289A1 Antimicrobial composition |
| 02/21/2007 | EP1648425B1 Process and Machine for the Automated Manufacture of Gastro-Retentive Capsules |
| 02/21/2007 | EP1608362B1 Stabilized pharmaceutical preparation comprising an amorphous active substance |
| 02/21/2007 | EP1545757B1 Perfluorocarbon emulsions with non-fluorinated surfactants |
| 02/21/2007 | EP1523325A4 Methods and compositions for treating polycystic ovary syndrome |
| 02/21/2007 | EP1463513B1 Stabilized brivudine topical formulations |
| 02/21/2007 | EP1389466B1 A dispersion on the basis of beta-glucan containing superfine particles, a corresponding process of manufacturing and the use of said dispersion |
| 02/21/2007 | EP1357901B1 Process for preparing particles |
| 02/21/2007 | EP1356811B1 Combination of three substances for the prevention or treatment of arthritis |
| 02/21/2007 | EP1328254B1 Lipid formulations for target delivery |
| 02/21/2007 | EP1276459B8 Cosmetic or dermatological cream composition, the preparation and the use thereof |
| 02/21/2007 | EP1255749B1 Tyrosine derivatives with anti-leukotriene activity |
| 02/21/2007 | EP1239842B1 Electrostatic application of powder material to solid dosage forms |
| 02/21/2007 | EP1231906B1 Transdermal therapeutic system containing highly volatile active ingredients |
| 02/21/2007 | EP1222932B1 Compositions for electroporation |
| 02/21/2007 | EP1189602B1 Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 02/21/2007 | EP1140128B2 Method of using steam ironing of fabrics as a way of causing reduction of physiological and/or subjective reactivity to stress in humans |
| 02/21/2007 | EP1140071B1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 02/21/2007 | EP1034007B1 METHOD FOR THE PRODUCTION OF A ONE DOSE SYRINGE, COMPRISING A FREEZE-DRIED PROTEIN COMPOSITION, FOR ADMINISTERING A VOLUME LESS THAN 0.5 ml |
| 02/21/2007 | EP0975333B1 Sustained-release alginate gels |
| 02/21/2007 | CN2870895Y Electron biological electrothermal therapeutic paste |
| 02/21/2007 | CN2870885Y Long-effective depressor submerged rod |
| 02/21/2007 | CN2870840Y Tooth paste |
| 02/21/2007 | CN1918298A Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation |
| 02/21/2007 | CN1917939A Device, method and use for the formation of small particles |
| 02/21/2007 | CN1917917A Osmotic pump with means for dissipating internal pressure |
| 02/21/2007 | CN1917891A Medicament on the basis of honey, preparation and use thereof |
| 02/21/2007 | CN1917888A Solid formulation for dialysis and process for producing the same |
| 02/21/2007 | CN1917883A Use of treprostinil to improve kidney functions |
| 02/21/2007 | CN1917863A Controlled release formulations of opioid and nonopioid analgesics |
| 02/21/2007 | CN1917862A Dosage form that is safeguarded from abuse |
| 02/21/2007 | CN1917861A Stabilised compositions of factor vii polypeptides |
| 02/21/2007 | CN1917860A Multiparticulate o-desmethylvenlafaxine salts and uses thereof |
| 02/21/2007 | CN1917859A Drug-containing nanoparticle, process for producing the same and parenterally administered preparation from the nanoparticle |
| 02/21/2007 | CN1917858A A microemulsion preparation of high concentration propofol for anesthetic uses |
| 02/21/2007 | CN1917857A Capillary moderator in an osmotic delivery system for preventing backflow into the active agent reservoir |
| 02/21/2007 | CN1917836A Sequestered reactive materials |
| 02/21/2007 | CN1916064A Dry powder of gelatinous polysaccharide of aloe, producing method and preparation |
| 02/21/2007 | CN1915986A High purified tanshinone óÄA sodium sulfonate, fabricating method, and preparation |
| 02/21/2007 | CN1915971A Prostaglandin-like compound and its uses for treatment of external secretion disorders |
| 02/21/2007 | CN1915968A Neutral-cationic lipid for nucleic acid and drug delivery |
| 02/21/2007 | CN1915423A Preparation of Chinese traditional medicine for treating gastric disease, and preparation method |
| 02/21/2007 | CN1915408A Compound preparation of Chinese traditional medicine in use for treating fatty liver, and preparation method |
| 02/21/2007 | CN1915404A Chinese traditional medicine for treating psoriasis |
| 02/21/2007 | CN1915401A Composition of Chinese traditional medicine for treating phthisis, and application |
| 02/21/2007 | CN1915399A Preparation for treating high blood pressure, high blood fat, obesity, and climacteric syndrome, and preparation method |
| 02/21/2007 | CN1915370A Massage cream of Chinese herbal medicine for removing spots and whitening skin |
| 02/21/2007 | CN1915352A Health product for reducing blood fat, and preparation method |
| 02/21/2007 | CN1915346A External remedy of cholagogue, and application |
| 02/21/2007 | CN1915344A Nutrient for cell growth, preparation method, and application of finished product in treating tumor, cardiovascular and cerebrovascular diseases |
| 02/21/2007 | CN1915343A Prepared Chinese medicine for treating slow healing of fracture |
| 02/21/2007 | CN1915337A Capsule of eye protector for patient of diabetes |
| 02/21/2007 | CN1915324A Preparation of reenforcing spleen for wean, and preparation method |
| 02/21/2007 | CN1915318A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915317A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915316A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915315A Enteric-coated prepartioon of compound rhizome of Sichuan lovage (notoperygium root) and Indomethacin, and preparation |
| 02/21/2007 | CN1915306A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915305A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915304A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915303A Drop pills of Chinese globeflower, and preparing technique |
| 02/21/2007 | CN1915301A Drop pills of corydalis tuber, and preparation method |
| 02/21/2007 | CN1915295A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915294A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915293A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915292A Application of acetylcholine esterase inhibitor medication of Yidancao extractive as cholinomimetic |
| 02/21/2007 | CN1915287A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915286A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915285A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915283A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915282A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915281A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915279A Medicinal composition, preparation method and quality control method |